NCT05316961

Brief Summary

This study aims to investigate the clinical effectiveness of PEMF as an adjunct to a program of eccentric exercise for the treatment of Achilles tendinopathy. The study objective is to establish whether PEMF plus eccentric exercise in people with Achilles tendinopathy will improve rehabilitation outcomes compared to eccentric exercise only. This study also investigates the effects of PEMF on pain, functional outcomes, mechanical and morphological properties of tendon among patients with Achilles tendinopathy. Investigators hypothesize that pulsed electromagnetic field therapy is effective in reducing pain, improving functional outcomes, and restoring mechanical and morphological properties of tendons in patients with Achilles tendinopathy. This study is a double-blinded, randomized controlled trial to investigate the clinical effects of pulsed electromagnetic field therapy (PEMF) for Achilles tendinopathy. Participants will be recruited from the outpatient clinic of the orthopedic and traumatology department at Prince of Wales Hospital. Fifty-four patients aged between 18 and 70 with Achilles tendinopathy will be invited to join this trial after informed consent. Participants will be randomized to any of the 2 groups: the intervention group (n=27; PEMF (Quantum Tx) treatment), and the control group (n=27; sham treatment with dummy exposure to PEMF). Baseline measurements of all self-reported outcomes, functional outcomes, and ultrasound imaging assessments, such as ankle range of motion, jumping ability, pain level, calf muscle strength, calf muscle endurance, physical activity level, quality of life by SF-36 will be measured.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 7, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

September 25, 2023

Status Verified

September 1, 2023

Enrollment Period

3.1 years

First QC Date

January 12, 2022

Last Update Submit

September 21, 2023

Conditions

Keywords

Pulsed electromagnetic field therapyEccentric exerciseRehabilitation

Outcome Measures

Primary Outcomes (2)

  • Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) requires participants to rate their pain on a defined scale from 0-10. 0 refers to no pain while 10 refers to severe pain. Lower scores mean a better outcome.

    Change from baseline to 6 months

  • Victorian Institute of Sport Assessment - Achilles questionnaire (VISA-A)

    The Victorian Institute of Sport Assessment - Achilles questionnaire (VISA-A) is used to evaluate the clinical severity of patients, monitor the change in symptoms and function following interventions provided for Achilles tendinopathy. The questionnaire contains eight questions, covering three necessary domains: 1) pain, 2) functional status, and 3) activity. The first seven questions have a score out of 10, and question 8 scores a maximum of 30. The minimum value is 0 and the maximum value is 100. Higher scores mean a better outcome. Asymptomatic individuals may score 100 points in VISA-A.

    Change from baseline to 6 months

Secondary Outcomes (6)

  • Ankle range of motion

    Change from baseline to 6 months

  • Calf muscle endurance

    Change from baseline to 6 months

  • Tendon thickness

    Change from baseline to 6 months

  • Neovascularity

    Change from baseline to 6 months

  • Tendon elasticity

    Change from baseline to 6 months

  • +1 more secondary outcomes

Study Arms (2)

PEMF group

EXPERIMENTAL

Participants will receive active pulsed electromagnetic field therapy two times a week for eight weeks. The options of the appliance will be adjusted to 1.5 mT, 10Hz on one leg for 10 minutes. A total of 16 sessions will be given to each participant. Each session will last for 10 minutes. Participants will be positioned in sitting on a chair comfortably. They will receive intervention at Prince of Wales hospital. 3 sets of 10 repetitions of the eccentric exercises are carried out once daily for 6 weeks and after 6 weeks, the patients are instructed to carry out 3 sets of 10 repetitions, 3 times per week for 6 more weeks. The intensity of the exercise should be such that pain, or discomfort, is experienced in the last set of 10 repetitions.

Device: Active PEMFOther: Eccentric exercise

Sham group

SHAM COMPARATOR

Participants will receive sham pulsed electromagnetic field therapy two times a week for eight weeks. The options of the appliance will be adjusted to 0 mT, 0Hz on one leg for 10 minutes. A total of 16 sessions will be given to each participant. Each session will last for 10 minutes. Participants will be positioned in sitting on a chair comfortably. They will receive intervention at Prince of Wales hospital. 3 sets of 10 repetitions of the eccentric exercises are carried out once daily for 6 weeks and after 6 weeks, the patients are instructed to carry out 3 sets of 10 repetitions, 3 times per week for 6 more weeks. The intensity of the exercise should be such that pain, or discomfort, is experienced in the last set of 10 repetitions.

Device: Sham PEMFOther: Eccentric exercise

Interventions

PEMF 1.5mT, 10Hz, 10 minutes

PEMF group
Sham PEMFDEVICE

PEMF 0mT, 0Hz, 10 minutes

Sham group

Eccentric exercise, 10 repetitions, 3 sets

PEMF groupSham group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 70
  • Tenderness with palpation 2-6 cm above the Achilles tendon insertion on the calcaneus (midportion Achilles tendinopathy)
  • Recurrent complaints in 1 or both Achilles' tendons at rest and/or during exercise for the preceding 3 month
  • Structural changes of the tendon were confirmed via sonographic examination during the initial physical exam
  • Achilles tendinopathy affecting the insertional and mid-portion of the Achilles tendon
  • Clinical symptoms associated with Achilles tendinopathy that do not respond well to conventional conservative treatments before entering the study
  • Informed consent

You may not qualify if:

  • History of surgery on the affected lower limb in the past year
  • Mental/physical limitation rendering participant to follow instructions
  • With medical or musculoskeletal problems that could affect the ability to complete assessments (i.e. with walking aids or wheel-chaired)
  • Severe cognitive impairments and neurological disorders that will affect data collection by questionnaires
  • Fractures of the trained body parts within the past 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KO Man Chi

Hong Kong, 999077, Hong Kong

Location

Related Publications (2)

  • Ko VM, Chen SC, He X, Fu SC, Franco-Obregon A, Yung PS, Ling SK. Short-term Effects of Pulsed Electromagnetic Field Therapy for Achilles Tendinopathy: A Randomized Controlled Trial. Orthop J Sports Med. 2024 Nov 12;12(11):23259671241284772. doi: 10.1177/23259671241284772. eCollection 2024 Nov.

  • Ko VM, He X, Fu SC, Yung PS, Ling SK. Clinical effectiveness of pulsed electromagnetic field therapy as an adjunct treatment to eccentric exercise for Achilles tendinopathy: a randomised controlled trial. Trials. 2023 Jun 12;24(1):394. doi: 10.1186/s13063-023-07434-6.

Study Officials

  • Ka-Kin Samuel Ling, MSc

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor (Clinical) of Orthopaedics & Traumatology

Study Record Dates

First Submitted

January 12, 2022

First Posted

April 7, 2022

Study Start

July 1, 2021

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

September 25, 2023

Record last verified: 2023-09

Locations